Picture of CNBX Pharmaceuticals logo

CNBX CNBX Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for CNBX Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

2021
August 31st
2022
August 31st
2023
August 31st
2024
August 31st
2025
August 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments1.390.1180.130.0260.015
Prepaid Expenses
Total Current Assets1.590.1980.2240.0310.018
Net Property, Plant And Equipment0.6430.4370.27500
Long Term Investments
Total Assets3.080.8110.4990.0310.018
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities1.272.442.522.512.51
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1.272.442.522.512.51
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity1.81-1.63-2.02-2.48-2.5
Total Liabilities & Shareholders' Equity3.080.8110.4990.0310.018
Total Common Shares Outstanding